Follow
Lynnette Fernandez-Cuesta
Lynnette Fernandez-Cuesta
Rare Cancers Genomics Team leader, IARC-WHO
Verified email at iarc.fr - Homepage
Title
Cited by
Cited by
Year
Comprehensive genomic profiles of small cell lung cancer
J George, JS Lim, SJ Jang, Y Cun, L Ozretić, G Kong, F Leenders, X Lu, ...
Nature 524 (7563), 47-53, 2015
19442015
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
M Peifer, L Fernández-Cuesta, ML Sos, J George, D Seidel, LH Kasper, ...
Nature genetics 44 (10), 1104-1110, 2012
14472012
A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal
G Rindi, DS Klimstra, B Abedi-Ardekani, SL Asa, FT Bosman, E Brambilla, ...
Modern Pathology 31 (12), 1770-1786, 2018
9372018
Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1
K Ohashi, LV Sequist, ME Arcila, T Moran, J Chmielecki, YL Lin, Y Pan, ...
Proceedings of the National Academy of Sciences 109 (31), E2127-E2133, 2012
5072012
Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids
L Fernandez-Cuesta, M Peifer, X Lu, R Sun, L Ozretić, D Seidel, T Zander, ...
Nature communications 5 (1), 3518, 2014
2882014
Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors
J George, V Walter, M Peifer, LB Alexandrov, D Seidel, F Leenders, ...
Nature communications 9 (1), 1048, 2018
2832018
CD74–NRG1 Fusions in Lung Adenocarcinoma
L Fernandez-Cuesta, D Plenker, H Osada, R Sun, R Menon, F Leenders, ...
Cancer discovery 4 (4), 415-422, 2014
2762014
Heterogeneous mechanisms of primary and acquired resistance to third-generation EGFR inhibitors
S Ortiz-Cuaran, M Scheffler, D Plenker, L Dahmen, AH Scheel, ...
Clinical Cancer Research 22 (19), 4837-4847, 2016
2562016
Identification of circulating tumor DNA for the early detection of small-cell lung cancer
L Fernandez-Cuesta, S Perdomo, PH Avogbe, N Leblay, TM Delhomme, ...
EBioMedicine 10, 117-123, 2016
1982016
Molecular subtypes of pulmonary large-cell neuroendocrine carcinoma predict chemotherapy treatment outcome
JL Derks, N Leblay, E Thunnissen, RJ Van Suylen, M den Bakker, ...
Clinical Cancer Research 24 (1), 33-42, 2018
1812018
EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach
AG Nicholson, JL Sauter, AK Nowak, HL Kindler, RR Gill, M Remy-Jardin, ...
Journal of Thoracic Oncology 15 (1), 29-49, 2020
1432020
Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids
N Alcala, N Leblay, AAG Gabriel, L Mangiante, D Hervás, T Giffon, ...
Nature communications 10 (1), 3407, 2019
1402019
New insights into the molecular characteristics of pulmonary carcinoids and large cell neuroendocrine carcinomas, and the impact on their clinical management
JL Derks, N Leblay, S Lantuejoul, AMC Dingemans, EJM Speel, ...
Journal of Thoracic Oncology 13 (6), 752-766, 2018
1192018
Cell-Autonomous and Non–Cell-Autonomous Mechanisms of Transformation by Amplified FGFR1 in Lung Cancer
F Malchers, F Dietlein, J Schöttle, X Lu, L Nogova, K Albus, ...
Cancer discovery 4 (2), 246-257, 2014
1172014
Shared oncogenic pathways implicated in both virus-positive and UV-induced Merkel cell carcinomas
M del Carmen Gonzalez-Vela, S Curiel-Olmo, S Derdak, S Beltran, ...
Journal of Investigative Dermatology 137 (1), 197-206, 2017
882017
Molecular Pathways: Targeting NRG1 Fusions in Lung Cancer
L Fernandez-Cuesta, RK Thomas
Clinical Cancer Research 21 (9), 1989-1994, 2015
872015
p53 regulates the transcription of its Δ133p53 isoform through specific response elements contained within the TP53 P2 internal promoter
V Marcel, V Vijayakumar, L Fernandez-Cuesta, H Hafsi, C Sagne, ...
Oncogene 29 (18), 2691-2700, 2010
862010
BAP1 is altered by copy number loss, mutation, and/or loss of protein expression in more than 70% of malignant peritoneal mesotheliomas
N Leblay, F Leprętre, N Le Stang, A Gautier-Stein, L Villeneuve, S Isaac, ...
Journal of Thoracic Oncology 12 (4), 724-733, 2017
822017
Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations
S Lorenz, T Barřy, J Sun, T Nome, D Vodák, JC Bryne, AM Hĺkelien, ...
Oncotarget 7 (5), 5273, 2016
802016
Prognostic and predictive value of TP53mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant …
L Fernández-Cuesta, C Oakman, P Falagan-Lotsch, E Quinaux, M Buyse, ...
Breast Cancer Research 14, 1-13, 2012
722012
The system can't perform the operation now. Try again later.
Articles 1–20